The Application of KMG in Artery Embolization for Uterine Fibroids

Objective To evaluate the therapeutic effect of KMG in uterine artery embolization for uterine fibroids. Meterials and Methods: Three patients with multi-uterine fibroids were performed uterine artery embolization with KMG(300 m -700 m). In all cases,the size, number, clinical symptom and sign of uterine fibroids, as well as the levels of ovary hormones were compared before and after artery embolization. The patients received sonographic follow-up at the first and the third months after the embolization, and ovary hormones were measured three months after embolization. After that, they were followed up by US for every two years. Results: The ages of the patients were 40,41 and 43 years(mean age 41.5 years). There was no significant change in level of ovary hormones before embolization and three months after embolization. The symptoms were improved during one month after embolization, the tumor size reduced 40% on average. In addition, four small tumors of them disappeared. At three months, the reduction reached 50%-60% and five of them disappeared With no clinical symptoms. All patients, who were followed up for 42 months on average,had no new tumors, while the rest fibroids were progressive reduction in size. The adverse reactions of embolization included pain, nausea, vomiting and fever. There were no serious adverse reactions. Conclusion: Artery embolization with KMG is a convenient, safety and effective method for the treatment of uterine fibroids.